resistin-like α Antibodies

Santa Cruz Biotechnology delivers a wide array of resistin-like α monoclonal antibodies for research focused on understanding this important protein. resistin-like α Antibodies are suitable for various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Resistin-like α, also known as RELMα, is a secreted protein that plays a significant role in regulating inflammation and metabolism. It is primarily expressed in adipose tissue and has been implicated in obesity-related insulin resistance and metabolic disorders. Understanding the function of resistin-like α is crucial for developing therapeutic strategies targeting metabolic diseases. Resistin-like α research has revealed important connections between adipose tissue function and systemic metabolic regulation. Recent studies have highlighted the potential of resistin-like α as a therapeutic target in metabolic disorders. Ongoing investigations continue to uncover new aspects of resistin-like α signaling pathways and their physiological implications. Santa Cruz Biotechnology monoclonal antibodies for resistin-like α support researchers worldwide in advancing our understanding of metabolic diseases and potential therapeutic interventions.